Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen

被引:95
作者
Ono, T
Kurashige, T
Harada, N
Noguchi, Y
Saika, T
Niikawa, N
Aoe, M
Nakamura, S
Higashi, T
Hiraki, A
Wada, H
Kumon, H
Old, LJ
Nakayama, E
机构
[1] Okayama Univ, Sch Med, Dept Immunol, Okayama 7008558, Japan
[2] Okayama Univ, Sch Med, Dept Surg 2, Okayama 7008558, Japan
[3] Okayama Univ, Sch Med, Dept Urol, Okayama 7008558, Japan
[4] Okayama Univ, Sch Med, Dept Internal Med 1, Okayama 7008558, Japan
[5] Okayama Univ, Sch Med, Dept Internal Med 2, Okayama 7008558, Japan
[6] Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 8528523, Japan
[7] Osaka Univ, Grad Sch Med, Dept Surg 2, Suita, Osaka 5650871, Japan
[8] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York, NY 10021 USA
关键词
testis cDNA; PCR cloning; antibody response;
D O I
10.1073/pnas.041625098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Serological expression cloning of antigens eliciting a humoral immune response to a syngeneic mouse sarcoma identified pem (mouse placenta and embryonic expression gene) as a new mem ber of the cancer/testis family. To identify the human homologue of pem, mouse pem sequences and pem-related expressed sequence tags from human testis were used as PCR primers for amplification using human testis cDNA. However, rather than pem, another gene, designated OY-TES-1, was isolated and found to be the human homologue of proacrosin binding protein sp32 precursor originally identified in mouse, guinea pig, and pig. OY-TES-1 maps to chromosome 12p12-p13 and contains 10 exons. Southern blot analysis suggests the presence of two OY-TES-1-related genes in the human genome. In normal tissues, OY-TES-1 mRNA was expressed only in testis, whereas in malignant tissues, a variable proportion of a wide array of cancers, including bladder, breast, lung, liver, and colon cancers, expressed OY-TES-1. Serological survey of 362 cancer patients with a range of different cancers showed antibody to OY-TES-1 in 25 patients. No OY-TES-1 sera reactivity was found in 20 normal individuals. These findings indicate that OY-TES-1 is an additional member of the cancer/testis family of antigens and that OY-TES-1 is immunogenic in humans.
引用
收藏
页码:3282 / 3287
页数:6
相关论文
共 49 条
[1]  
BABA T, 1994, J BIOL CHEM, V269, P10133
[2]   BAGE - A NEW GENE ENCODING AN ANTIGEN RECOGNIZED ON HUMAN MELANOMAS BY CYTOLYTIC T-LYMPHOCYTES [J].
BOEL, P ;
WILDMANN, C ;
SENSI, ML ;
BRASSEUR, R ;
RENAULD, JC ;
COULIE, P ;
BOON, T ;
VANDERBRUGGEN, P .
IMMUNITY, 1995, 2 (02) :167-175
[3]   THE TYROSINASE GENE CODES FOR AN ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS [J].
BRICHARD, V ;
VANPEL, A ;
WOLFEL, T ;
WOLFEL, C ;
DEPLAEN, E ;
LETHE, B ;
COULIE, P ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :489-495
[4]   Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes [J].
Chaux, P ;
Vantomme, V ;
Stroobant, V ;
Thielemans, K ;
Corthals, J ;
Luiten, R ;
Eggermont, AMM ;
Boon, T ;
van der Bruggen, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :767-777
[5]   Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library [J].
Chen, YT ;
Güre, AO ;
Tsang, S ;
Stockert, E ;
Jäger, E ;
Knuth, A ;
Old, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6919-6923
[6]   A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening [J].
Chen, YT ;
Scanlan, MJ ;
Sahin, U ;
Tureci, O ;
Gure, AO ;
Tsang, SL ;
Williamson, B ;
Stockert, E ;
Pfreundschuh, M ;
Old, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1914-1918
[7]   A NEW GENE CODING FOR A DIFFERENTIATION ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS [J].
COULIE, PG ;
BRICHARD, V ;
VANPEL, A ;
WOLFEL, T ;
SCHNEIDER, J ;
TRAVERSARI, C ;
MATTEI, S ;
DEPLAEN, E ;
LURQUIN, C ;
SZIKORA, JP ;
RENAULD, JC ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :35-42
[8]   IDENTIFICATION OF AN IMMUNODOMINANT PEPTIDE OF HER-2/NEU PROTOONCOGENE RECOGNIZED BY OVARIAN TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE LINES [J].
FISK, B ;
BLEVINS, TL ;
WHARTON, JT ;
IOANNIDES, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2109-2117
[9]   Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele [J].
Gnjatic, S ;
Nagata, Y ;
Jäger, E ;
Stockert, E ;
Shankara, S ;
Roberts, BL ;
Mazzara, GP ;
Lee, SY ;
Dunbar, PR ;
Dupont, B ;
Cerundolo, V ;
Ritter, G ;
Chen, YT ;
Knuth, A ;
Old, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (20) :10917-10922
[10]  
Güre AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO